A

PriceArcellx

ACLX

Arcellx Inc a clinical-stage biotechnology company reimagining cell therapy through the development of immunotherapies for patients with cancer and other incurable diseases. Its pipeline includes Multiple Myeloma, Acute Myeloid Leukemia, Non-Oncology, and Solid Tumors.

Historical stock price chart and annual return over the past years

243%

3 years

% Total

ACLX
51%

3 years

Annual Return

ACLX